Key result
Multivariable screening tool shows moderate discrimination for 30-day preventable medication-related readmissions in older adults.
Why the study?
Preventable medication-related readmissions contribute significantly to older adult morbidity, mortality, and healthcare costs, but no specific screening tools currently exist to identify patients at high risk.
Can a screening tool based on four pre-specified predictors identify older general internal medicine patients at high risk of 30-day preventable medication-related readmissions?
Case-Control (n=1,000)
Can a screening tool based on four pre-specified predictors identify older general internal medicine patients at high risk of 30-day preventable medication-related readmissions?
A newly developed screening tool using four clinical predictors showed moderate discriminatory power for identifying older adults at risk of 30-day preventable medication-related readmissions.
Answers are grounded in this paper and cite their sources.
May aid risk stratification in older adults; leaves open prospective validation before clinical use.
Background Preventable medication‐related readmissions (pMRRs) are a significant contributor to older adult morbidity, mortality, and health care costs. There are currently no specific screening tools for identifying patients at a high risk of pMRRs. This study aimed to develop and internally validate a screening tool to identify general internal medicine patients aged 65 or older at risk of 30‐day pMRRs. Methods Data on 500 patients discharged between January 1, 2022 and October 18, 2023, and readmitted within 30 days were reviewed, and 116 pMRRs were identified. An additional 500 control patients without pMRRs were selected. A multivariable logistic regression model was developed using the four pre‐specified predictors of each patient's number of medications, hospitalizations in the past year, high‐risk medications at discharge (anticoagulants, opioids, and sedatives), and the number of the following diagnoses: heart failure, diabetes, chronic kidney disease, and chronic obstructive pulmonary disease. Results The screening tool's performance was evaluated and internally validated using bootstrapping. The screening tool demonstrated moderate discriminatory power, with a C‐statistic of 0.714 (95% confidence interval [CI]: 0.663–0.764). Overall performance was assessed as acceptable, with a Brier score of 0.177. Bootstrapping yielded an optimism‐corrected C‐statistic of 0.704 (95% CI: 0.654–0.755), indicating the tool's robustness. Conclusions The screening tool's discriminatory power suggested its potential utility for flagging patients at risk of pMRRs. External validation and a search for additional predictors will be necessary to enhance the tool's performance and generalizability. If validated, a cost‐effectiveness analysis would be needed to ensure its feasibility for clinical implementation.
No takes yet. Share an insight, caveat, or question.
Schönenberger et al. (2025) conducted a case-control in Preventable medication-related readmissions (n=1,000). Multivariable screening tool was evaluated on Discriminatory power for 30-day preventable medication-related readmissions (C-statistic 0.714, 95% CI 0.663-0.764). A multivariable screening tool demonstrated moderate discriminatory power for identifying older adults at risk of 30-day preventable medication-related readmissions.
Synapse has enriched 10 related papers. Consider them for comparative context: